Caris Life Sciences Inc banner
C

Caris Life Sciences Inc
NASDAQ:CAI

Watchlist Manager
Caris Life Sciences Inc
NASDAQ:CAI
Watchlist
Price: 31.65 USD 0.57% Market Closed
Market Cap: $8.9B

Wall St Price Targets

CAI Price Forecast
Based on 13 analysts

-13% Downside
from $31.65 today

CAI Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CAI yet.

Caris Life Sciences Inc Competitors:
Price Targets

Revenue
Forecast

97% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
97% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been 97%. The projected CAGR for the next 8 years is 15%.

Gross Profit
Forecast

200% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
200% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Gross Profit has been 200%. The projected CAGR for the next 8 years is 16%.

Operating Income
Forecast

N/A
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 8 years is 39%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CAI's stock price target?
Price Target
27.54 USD

According to Wall Street analysts, the average 1-year price target for CAI is 27.54 USD with a low forecast of 22.22 USD and a high forecast of 34.65 USD.

What is the Revenue forecast for Caris Life Sciences Inc?
Projected CAGR
15%

Over the last 1 year, the compound annual growth rate for Revenue has been 97%. The projected CAGR for the next 8 years is 15%.

What is the Gross Profit forecast for Caris Life Sciences Inc?
Projected CAGR
16%

Over the last 1 year, the compound annual growth rate for Gross Profit has been 200%. The projected CAGR for the next 8 years is 16%.

What is the Operating Income forecast for Caris Life Sciences Inc?
Projected CAGR
39%

The compound annual growth rate for Operating Income over the next 8 years is 39%.

Back to Top